InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Harrison Seth Loring, Director. Director active across 1 company, notably Akero Therapeutics, Inc.. Aggregated, 10 disclosures have been published. Split: 0 buy · 6 sells. Total volume traded: €2.3m. History available since 25 October 2022. The latest transaction was filed on 30 November 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
136,301 sharesCommon StockSEC:0001193125-25-312127
136,301 sharesCommon StockSEC:0001193125-25-312127:0
148,063 sharesCommon StockSEC:0001193125-25-312127:1
9,398 sharesCommon StockSEC:0001193125-25-312127:2
6,322 shares@ US$46.435512.5% of flowCommon StockSEC:0000899243-22-037475:0
20,338 shares@ US$40.27936.2% of flowCommon StockSEC:0000899243-22-034709:0
800 shares@ US$41.12041.5% of flowCommon StockSEC:0000899243-22-034709:1
22,096 shares@ US$40.27939.3% of flowCommon StockSEC:0000899243-22-034709:2
869 shares@ US$41.12041.6% of flowCommon StockSEC:0000899243-22-034709:3
4,515 shares@ US$44.91639.0% of flowCommon StockSEC:0000899243-22-034377:0
10 of 10 declarations
About Harrison Seth Loring
Seth Loring Harrison is a Director at Akero Therapeutics, Inc. He contributes to the governance of the company and strategic decision-making. Seth brings his expertise in biotechnology to help Akero innovate and grow in the market.
